Blair Madison, Ph.D. 

Chief Scientific Officer, Gene Therapy

Dr. Madison is our Chief Scientific Officer, Gene Therapy, after joining Poseida in 2019 and most recently serving as Vice President, Genetic Engineering. At Poseida, he has played a leading role in advancing allogeneic CAR-T programs and developing key platforms, including the Cas-CLOVER nuclease and site-specific super piggyBac for applications in cell and gene therapies. Prior to Poseida, Dr. Madison was a tenure-track Assistant Professor of Medicine and a National Institutes of Health (NIH)-funded investigator at Washington University in St. Louis, Missouri, and before that was a Postdoctoral Fellow in genetics at the University of Pennsylvania. Earlier in his career, he led R&D efforts at Transposagen Biopharmaceuticals as the Vice President of Research. Dr. Madison holds a B.A. in Biology from Washington University and a Ph.D. in Cell and Molecular Biology from the University of Michigan.